Stay informed with the latest litigation news. Explore now

IP Verse

Il-15R Alpha Forms, Cells Expressing Il-15R Alpha Forms, And Therapeutic Uses Of Il-15R Alpha And Il-15/Il-15R Alpha Complexes - EP2911684B1

EP2911684

ADMUNE THERAPEUTICS
Application Number
EP13849581A
Filing Date
Oct 23, 2013
Status
Granted And Under Opposition
May 17, 2019
Grant Date
Jun 19, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2724728B1

Bibliography

The patent EP2911684B1 was granted to Admune Therapeutics on Jun 19, 2019 following the initial filing on Oct 23, 2013 under the application number EP13849581A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GRAF VON STOSCHMar 19, 2020WITHDRAWN

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents